Language Select
Varian Logo

INVESTOR RELATIONS

Our Mission is to Focus Energy on Saving Lives.

Varian Partners with Penn Medicine for Proton Therapy Training and Education Program

PALO ALTO, Calif., Nov. 28, 2017 /PRNewswire/ -- Varian (NYSE: VAR) today announced it is partnering with Penn Medicine to develop and launch a comprehensive proton therapy training and education program. Comprised of both online and in-person training sessions, participants will have the opportunity to learn key clinical concepts firsthand from proton therapy experts at Penn Medicine. The program will cover all aspects of proton therapy, from patient selection and planning through treatment and follow-up. In-person training and online courses will be available starting January 2018.

The in-person training consists of up to 40 weeks of onsite training at Penn Medicine in Philadelphia. During these training sessions, participants will be able to work directly with the experts in a clinical environment. The immersive program allows for in-clinic observation and live hands-on learning. The online program will offer over 80 different training models designed and led by proton therapy experts from Penn Medicine. The modules cover all aspects of proton therapy from the basics of proton therapy, to beam commissioning and quality assurance, to extensive review of clinical topics and outcomes. For more information on this training program, visit https://www.varian.com/proton-training.

"We are proud to be partnering with Penn Medicine on this new comprehensive proton therapy training program," said Dr. Moataz Karmalawy, general manager of Varian's Particle Therapy division. "Continued education and training is playing an important role in the growing availability of proton therapy. Through this new program we have the ability to expand the knowledge and skills of clinicians and therapists in proton therapy around the world."

About Varian
Varian focuses energy on saving lives and is the world's leading manufacturer of medical devices and software for treating and managing cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,500 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.

Press Contact
Mark Plungy
Varian Medical Systems
+1 (650) 424-5630
mark.plungy@varian.com

 

SOURCE Varian

  • Follow Us

Production of any of the material contained herein in any format or media without the express written permission of Varian Medical Systems is prohibited.

Varian Logo